LAG3 and melanoma: Furthermore, expression of LAG-3 on regulatory CD4 T cells identified a more immunosuppressive phenotype, which subsequently hindered CD8 T cell function in Hodgkin’s lymphoma (Gandhi et al. 2006), melanoma and colorectal cancer (Camisaschi et al. 2010).